Movicol Pediátrico Sabor Neutro

Macrogol 3350 with electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride), the active ingredient in Movicol Pediátrico Sabor Neutro, is an osmotic laxative presented as an oral solution for oral use. It treats constipation in children, faecal impaction and is used for bowel preparation before diagnostic procedures.

GNH USA supplies Movicol Pediátrico Sabor Neutro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Pediátrico is an osmotic laxative used to manage conditions affecting bowel motility and stool consistency.

- Constipation in children: softens stool and facilitates regular bowel movements. - Faecal impaction: helps relieve hardened stool accumulation in the colon. - Bowel preparation for diagnostic procedures: clears the intestinal tract before colonoscopy or imaging.

Adverse reactions to Movicol Pediátrico are generally mild but can vary in frequency and severity.

Common Side Effects: - Abdominal pain: mild cramping or discomfort. - Diarrhoea: loose stools occurring more frequently. - Nausea: feeling of queasiness. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal sodium or potassium levels. - Severe dehydration: marked loss of body fluids. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

Before prescribing Movicol Pediátrico, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: assess kidney function before use. - Heart failure: monitor fluid status in patients with cardiac disease. - Electrolyte disorders: avoid in patients with existing electrolyte abnormalities. - Pediatric dosing: adjust dose according to age and weight as directed by prescriber. - Diarrhoea risk: discontinue if persistent watery stools develop. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture.

Movicol Pediátrico may interact with other medicines, altering their absorption or electrolyte balance.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity due to altered renal clearance. - Digoxin: potential for electrolyte shifts that affect digoxin levels.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminium: may reduce laxative efficacy. - Oral antibiotics: possible changes in gut flora affecting drug absorption. - Diuretics: concurrent use may exacerbate electrolyte disturbances.